We provide a clinically useful, reliable, comprehensive, up-to-date, evidence-based drug-drug interaction resource, freely available to healthcare workers, patients and researchers.
Around 37 million individuals are living worldwide with HIV and although advances in therapy have yielded effective regimens, individual antiretroviral drugs are amongst the most therapeutically risky for drug-drug interactions (DDI) presenting significant risks to patients and a challenge for health care providers to ensure safe and appropriate prescribing. In order to address this, the Liverpool Drug Interactions website was established in 1999 by members of the Department of Pharmacology at the University of Liverpool to provide a freely available drug-drug interaction resource.
We strongly believe that drug information should be offered free of charge, be independent, and be evidence-based and transparent. We have an international Editorial Board with strong patient and user involvement. We are convinced that quality of care is vitally important, particularly in resource-limited countries where health systems may be weak or fragmented, patient monitoring sparse, and where patient harms from DDIs may pass unnoticed. We actively promote the use of our Apps to healthcare providers and patients to enable rapid screening of DDIs.
Information presented relates only to known or suspected effects of interacting medications, and is based on relevant data in the public domain. No clinical advice is given or implied, clinicians must exercise their own judgement in relation to the risks and benefits of combining drugs, which depend on factors beyond pharmacokinetic interactions between two drugs. The University of Liverpool shall not be held responsible for the application or use of any information it gives and the user shall hold the University of Liverpool harmless against any consequences arising from the same.